Home » AdvaMed CEO Panel: Medtech Needs ‘Leapfrog-Type Improvements’
AdvaMed CEO Panel: Medtech Needs ‘Leapfrog-Type Improvements’
What should the medical device industry do now, as it faces a perfect storm of a tight funding climate, price pressures, a tough regulatory environment, as well as the new medical device tax? “It has probably never been harder to bring a device from the bench to the bedside,” reflected Stephen Ubl, AdvaMed president and CEO, who served as a moderator for the AdvaMed CEOs Unplugged Panel.
MDDI
MDDI
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May